News

Filter

Current filters:

Generics

151 to 160 of 96128 results

Benefit for once-daily Xarelto in the first trial to evaluate prospective use in AF patients undergoing cardioversion

Benefit for once-daily Xarelto in the first trial to evaluate prospective use in AF patients undergoing cardioversion

02-09-2014

German pharma and chemical major Bayer has released results from the X-VeRT* study, demonstrating that…

BayerCardio-vascularPharmaceuticalResearchXarelto

bluebird bio poised to advance gene therapy pipeline

bluebird bio poised to advance gene therapy pipeline

02-09-2014

US clinical-stage biotech firm bluebird bio is advancing a pipeline focused on gene therapy, a rapidly…

Biotechnologybluebird bioCelgene Corp.OncologyRare diseasesResearch

Novo Nordisk pulls out of inflammatory disorders research

Novo Nordisk pulls out of inflammatory disorders research

02-09-2014

Danish diabetes care giant Novo Nordisk says it has decided to discontinue all its R&D activities within…

Anti-Arthritics/RheumaticsInflammatory diseasesNovo NordiskPharmaceutical

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

01-09-2014

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo…

AdvairCiplaGenericsIndiaMarkets & MarketingRespiratory and Pulmonary

New EMA guidance on EU periodic-safety-update-report single assessment for nationally authorized medicines

01-09-2014

The European Medicines Agency has updated its procedural guidance to ensure that marketing-authorization…

EuropePharmaceuticalRegulation

Boehringer plans new real-world data on Pradaxa

01-09-2014

Five years on from the first breakthrough presentation of the pivotal RE-LY clinical trial of Pradaxa…

Boehringer IngelheimCardio-vascularPharmaceuticalPradaxaResearch

151 to 160 of 96128 results

Back to top